Blocknomi
Key Takeaways JNJ stock rises modestly following positive JASMINE lupus trial outcomes. Phase 2 study demonstrates nipocalimab maintains disease control over 52 weeks. Autoantibody-positive patients show particularly encouraging response rates.…
Related articles
-
Bitcoin Could Record Its Largest Weekly Loss in Years if It Breaks Below This Support
The Crypto Basic Published 28.05.2026 10:50
-
Pi Network (PI) Price Predictions for This Week (June 4)
CryptoPotato Published 04.06.2026 09:15
-
Stake DAO Exploit Shows Why “Audited” Doesn’t Mean Safe In DeFi
BeInCrypto Published 27.05.2026 12:32
-
CFTC chair claims Gemini case was politically motivated, seeks to reverse $5M settlement
Cointelegraph Published 02.06.2026 17:39
-
Strive Passes Coinbase and Riot After New Bitcoin Treasury Buy
Blocknomi Published 26.05.2026 18:34
-
Bitcoin treasury company Nakamoto falls nearly 67% YTD after reverse stock split
Cointelegraph Published 27.05.2026 19:40
-
Tether plans GELT stablecoin launch with support from Georgian government
The Block Published 25.05.2026 09:14
-
S&P 500 Breadth Paradox: Why Record Highs Look Weaker Under the Surface
Crypto Daily Published 03.06.2026 11:21